Zaza Iakobishvili
Overview
Explore the profile of Zaza Iakobishvili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
1404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tocchetti C, Farmakis D, Koop Y, Andres M, Couch L, Formisano L, et al.
Eur J Heart Fail
. 2024 Aug;
26(10):2055-2076.
PMID: 39087551
The advent of immunological therapies has revolutionized the treatment of solid and haematological cancers over the last decade. Licensed therapies which activate the immune system to target cancer cells can...
2.
Marincheva G, Iakobishvili Z, Valdman A, Laish-Farkash A
Rev Cardiovasc Med
. 2024 Jul;
23(5):154.
PMID: 39077588
Atrial cardiomyopathy represents a process of structural and functional changes affecting the atria and leading eventually to clinical manifestation of atrial fibrillation and risk of stroke. Multimodality imaging provides a...
3.
Teske A, Moudgil R, Lopez-Fernandez T, Barac A, Brown S, Deswal A, et al.
Circ Cardiovasc Qual Outcomes
. 2023 Sep;
16(10):e009905.
PMID: 37702048
Background: Global collaboration in cardio-oncology is needed to understand the prevalence of cancer therapy-related cardiovascular toxicity in different risk groups, practice settings, and geographic locations. There are limited data on...
4.
Nadarajah R, Younsi T, Romer E, Raveendra K, Nakao Y, Nakao K, et al.
Eur J Heart Fail
. 2023 Jul;
25(10):1724-1738.
PMID: 37403669
Aims: Multivariable prediction models can be used to estimate risk of incident heart failure (HF) in the general population. A systematic review and meta-analysis was performed to determine the performance...
5.
Klimis H, Pinthus J, Aghel N, Duceppe E, Fradet V, Brown I, et al.
JACC CardioOncol
. 2023 Mar;
5(1):70-81.
PMID: 36875906
Background: Cardiovascular disease (CVD) incidence is higher in men with prostate cancer (PC) than without. Objectives: We describe the rate and correlates of poor cardiovascular risk factor control among men...
6.
Ludman P, Zeymer U, Danchin N, Kala P, Laroche C, Sadeghi M, et al.
Eur Heart J Acute Cardiovasc Care
. 2022 Nov;
12(1):22-37.
PMID: 36346109
Aims: To use quality indicators to study the management of ST-segment elevation myocardial infarction (STEMI) in different regions. Methods And Results: Prospective cohort study of STEMI within 24 h of...
7.
Berkovitch A, Iakobishvili Z, Fuchs S, Atar S, Braver O, Eisen A, et al.
Front Cardiovasc Med
. 2022 Sep;
9:902615.
PMID: 36148064
Objectives: Ankle-brachial index (ABI) is an independent prognostic marker of cardiovascular events among patients with coronary artery disease (CAD). We aimed to investigate the outcome of patients hospitalized with acute...
8.
Ram E, Fisman E, Tenenbaum A, Iakobishvili Z, Peled Y, Raanani E, et al.
Cardiovasc Diabetol
. 2022 Sep;
21(1):175.
PMID: 36064537
Background: To compare the outcomes of diabetic patients hospitalized with non-ST elevation myocardial infarction (NSTEMI) or unstable angina (UA) referred for revascularization by either coronary artery bypass grafting (CABG) or...
9.
Matetzky S, Natanzon S, Shlomo N, Atar S, Pollak A, Yosefy C, et al.
Heart Lung Circ
. 2022 May;
31(8):1093-1101.
PMID: 35613975
Background: Limited data exist regarding the significance of peripheral arterial disease (PAD) in patients with acute coronary syndrome (ACS). Methods: We evaluated 16,922 consecutive ACS patients who were prospectively included...
10.
Nardi-Agmon I, Zer A, Peysakhovich Y, Margalit I, Kornowski R, Peled N, et al.
Isr Med Assoc J
. 2022 Mar;
24(3):135-139.
PMID: 35347923
Background: No specific clinical or histological factors are recognized to be associated with the development of pericardial effusion in non-small cell lung cancer (NSCLC) other than a metastatic disease. Objectives:...